INS and obesity disorder: Evidence for the key role of insulin in androgen production in obesity and hyperinsulinemia is the significant reduction in testosterone and androstendione concentrations, following weight reduction, decreased insulin levels, and improved insulin sensitivity in patients treated with diet and pharmacological therapy [26,27,28].